Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,634 | 77 | 97.6% |
| Education | $40.00 | 1 | 2.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $380.93 | 16 | $0 (2024) |
| PFIZER INC. | $366.22 | 23 | $0 (2024) |
| Medtronic, Inc. | $253.56 | 2 | $0 (2024) |
| Lilly USA, LLC | $77.41 | 5 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $67.67 | 5 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $65.74 | 4 | $0 (2024) |
| Allergan, Inc. | $51.60 | 2 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $51.33 | 1 | $0 (2017) |
| Mylan Specialty L.P. | $47.84 | 2 | $0 (2023) |
| Amarin Pharma Inc. | $46.91 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $257.11 | 8 | Medtronic, Inc. ($132.70) |
| 2023 | $251.29 | 8 | Medtronic, Inc. ($120.86) |
| 2022 | $99.07 | 6 | Novo Nordisk Inc ($20.16) |
| 2021 | $78.22 | 5 | Abbott Laboratories ($23.05) |
| 2020 | $80.10 | 4 | Allergan, Inc. ($40.00) |
| 2019 | $200.85 | 13 | PFIZER INC. ($60.53) |
| 2018 | $472.62 | 26 | PFIZER INC. ($251.63) |
| 2017 | $234.57 | 8 | Novo Nordisk Inc ($61.45) |
All Payment Transactions
78 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | Verrica Pharmaceuticals Inc. | YCANTH (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: DERMATOLOGY | ||||||
| 09/04/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: Diabetes | ||||||
| 08/21/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: VACCINES | ||||||
| 07/12/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $19.98 | General |
| 06/12/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $19.23 | General |
| 04/24/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: Oncology | ||||||
| 02/07/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Respiratory | ||||||
| 01/30/2024 | Medtronic, Inc. | CLOSUREFAST (Device) | Food and Beverage | In-kind items and services | $132.70 | General |
| Category: EndoVenous Therapies | ||||||
| 10/04/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $31.91 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 09/27/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Diabetes | ||||||
| 04/12/2023 | Cranial Technologies, Inc | Doc Band (Device) | Food and Beverage | Cash or cash equivalent | $13.99 | General |
| Category: Cranial Orthotic | ||||||
| 04/06/2023 | Medtronic, Inc. | HAWKONE (Device) | Food and Beverage | In-kind items and services | $120.86 | General |
| Category: Directional Atherectomy Devices | ||||||
| 04/05/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Diabetes | ||||||
| 02/23/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: Diabetes | ||||||
| 02/08/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/02/2023 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Neuroscience | ||||||
| 12/16/2022 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Neurology | ||||||
| 11/30/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: Diabetes | ||||||
| 11/02/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: Diabetes | ||||||
| 08/11/2022 | PFIZER INC. | PREVNAR 13 (Biological), TRUMENBA, PREVNAR 20 | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: VACCINES | ||||||
| 05/11/2022 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 03/09/2022 | Cranial Technologies, Inc | Doc Band (Device) | Food and Beverage | Cash or cash equivalent | $13.49 | General |
| Category: Cranial Orthotic | ||||||
| 10/13/2021 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $11.78 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 09/16/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.20 | General |
| Category: Cardiovascular | ||||||
| 07/27/2021 | Abbott Laboratories | FreeStyle Libre 2 (Device) | Food and Beverage | In-kind items and services | $23.05 | General |
| Category: Diabetes Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 373 | 517 | $74,755 | $29,986 |
| 2022 | 10 | 345 | 459 | $67,014 | $26,834 |
| 2021 | 9 | 364 | 511 | $76,748 | $30,147 |
| 2020 | 12 | 387 | 529 | $80,805 | $33,117 |
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 96 | 103 | $26,162 | $9,541 | 36.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 76 | 156 | $22,152 | $9,438 | 42.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 57 | 59 | $10,738 | $5,272 | 49.1% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 37 | 71 | $6,603 | $2,717 | 41.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 34 | 35 | $4,550 | $2,038 | 44.8% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 11 | 12 | $1,800 | $739.14 | 41.1% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2023 | 25 | 29 | $1,450 | $126.10 | 8.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 37 | 52 | $1,300 | $114.40 | 8.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 79 | 157 | $22,294 | $8,673 | 38.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 44 | 45 | $13,860 | $6,577 | 47.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 40 | 42 | $10,668 | $4,334 | 40.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 50 | 51 | $6,630 | $2,854 | 43.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 22 | 22 | $4,004 | $1,743 | 43.5% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 29 | 41 | $3,813 | $1,230 | 32.3% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 17 | 17 | $1,020 | $723.99 | 71.0% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 16 | 17 | $2,550 | $519.47 | 20.4% |
| 81003 | Automated urinalysis test | Office | 2022 | 33 | 47 | $1,175 | $104.47 | 8.9% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2022 | 15 | 20 | $1,000 | $74.90 | 7.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 79 | 170 | $24,140 | $9,204 | 38.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 48 | 48 | $14,784 | $6,697 | 45.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 49 | 50 | $12,700 | $4,759 | 37.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 59 | 61 | $7,930 | $3,405 | 42.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 16 | 33 | $6,006 | $2,681 | 44.6% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 33 | 59 | $5,487 | $1,761 | 32.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 18 | 18 | $3,276 | $1,444 | 44.1% |
About Dr. Jon Bode, MD
Dr. Jon Bode, MD is a Family Medicine healthcare provider based in Brenham, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124090725.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jon Bode, MD has received a total of $1,674 in payments from pharmaceutical and medical device companies, with $257.11 received in 2024. These payments were reported across 78 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($1,634).
As a Medicare-enrolled provider, Bode has provided services to 1,469 Medicare beneficiaries, totaling 2,016 services with total Medicare billing of $120,084. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Brenham, TX
- Active Since 02/07/2006
- Last Updated 02/15/2013
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1124090725
Products in Payments
- Ozempic (Drug) $166.57
- EUCRISA (Drug) $149.90
- CLOSUREFAST (Device) $132.70
- HAWKONE (Device) $120.86
- Victoza (Drug) $96.85
- LYRICA (Drug) $88.80
- CHANTIX (Drug) $86.93
- ENTRESTO (Drug) $51.33
- MOUNJARO (Drug) $49.18
- FARXIGA (Drug) $48.51
- Vascepa (Drug) $46.91
- Doc Band (Device) $41.56
- VIIBRYD (Drug) $40.00
- Rybelsus (Drug) $38.18
- YUPELRI (Drug) $31.91
- Xofluza (Drug) $30.12
- TOUJEO (Drug) $29.73
- ClosureFast (Device) $26.71
- SOLIQUA 100/33 (Biological) $24.77
- FreeStyle Libre 2 (Device) $23.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Brenham
Dr. Nathan Simons, M.d, M.D
Family Medicine — Payments: $1,104
Dr. Francisco Leal, Md, MD
Family Medicine — Payments: $950.59
Eric Alford, Md, MD
Family Medicine — Payments: $724.66
Sean Holster, M.d, M.D
Family Medicine — Payments: $690.81
Christopher Gray, M.d, M.D
Family Medicine — Payments: $272.41
Dr. Caitlin Conner, Md, MD
Family Medicine — Payments: $183.77